Stay updated on Pembrolizumab and Epacadostat in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page
- Check5 days agoChange DetectedUI enhancements include a Show glossary option and color-coded highlights for added/deleted items. The revision label updates from v3.3.4 to v3.4.0, and the No FEAR Act Data capitalization is adjusted.SummaryDifference0.9%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA new record history entry, Revision: v3.3.4, was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedThe new screenshot shows an added 'Revision: v3.3.3' line and removal of 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the footer, reflecting a minor site revision. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check69 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.2.0 from the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check76 days agoChange DetectedThe government funding status banner was removed from the page; the study history table and links remain unchanged.SummaryDifference0.6%

- Check90 days agoChange DetectedThe new screenshot shows a minor visual refresh of the Record History page (slightly different header/footer styling) with no additions or removals in the version list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab and Epacadostat in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page.